Overall rank by patents
#33,011
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).
The verdict
According to USPTO PatentsView, Rayotek ranks #33,011 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 12 technology areas.
USPTO PatentsView assignee plate
Corpus R33011 · US Corporation #33,011 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Ranbaxy Laboratories Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Rayotek Scientific · this assignee
34 score
3D Lighting… · lowest
7 score
What this shows Rayotek's Innovation Score is 33.9/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Rayotek Scientific, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 25% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2015. By volume, Rayotek sits between Ranbaxy Laboratories Limited and Reapplix APS.
Rayotek Scientific, Inc. shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ranbaxy Laboratories Limited
8 patents
Raontech, Inc.
8 patents
Raydiall
8 patents
Raylase GmbH
8 patents
RB&W Manufacturing LLC
8 patents
Re-dai Precision Tools Co., Ltd.
8 patents
RE2, Inc.
8 patents
Reapplix APS
8 patents
Rayotek Scientific, Inc.
8 patents
What this shows Rayotek holds 8 patents at rank #32,985, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,985 in granted patent volume.
Other assignees with the most granted patents in Rayotek's primary technology class.
Rayotek's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 46th percentile higher than 46% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 12.5% |
| 2016 | 3 | 37.5% |
| 2017 | 1 | 12.5% |
| 2020 | 1 | 12.5% |
| 2023 | 1 | 12.5% |
| 2025partial year | 1 | 12.5% |
Top 12 of 12 technology areas
Overall rank by patents
#33,011
of 49,997 tracked assignees
33.9 out of 100
What to do with this data
Rayotek Scientific, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.